Sundar.M
☆    

India,
2019-02-15 13:37

Posting: # 19925
Views: 271
 

 Dose curve [PK / PD]

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,490 posts in 4,135 threads, 1,335 registered users;
online 12 (0 registered, 12 guests [including 6 identified bots]).
Forum time (Europe/Vienna): 13:43 CEST

Not to be absolutely certain is, I think,
one of the essential things in rationality.    Bertrand Russell

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5